Luteolin-phospholipid complex: Preparation, characterization and biological evaluation

Journal of Pharmacy and Pharmacology

Volumn 66, Issue 10, 2014, Pages 1451-1462

  Khan, Junaid ^a   Alexander, Amit ^a   Ajazuddin, A ^b   Saraf, Swarnlata ^a   Saraf, Shailendra ^a  

^a PT RAVISHANKAR SHUKLA UNIVERSITY   (India)

^b RUNGTA COLLEGE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

Author keywords

inflammation; luteolin; phospholipid complex; solubility

Indexed keywords

ANTIINFLAMMATORY AGENT; DRUG CARRIER; LUTEOLIN; PHOSPHOLIPID; PLANT EXTRACT; WATER;

ANIMAL; BIOAVAILABILITY; CHEMICALLY INDUCED; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG STABILITY; FEMALE; INFLAMMATION; INFRARED SPECTROSCOPY; MALE; MEDICINAL CHEMISTRY; MOUSE; PARTICLE SIZE; SOLUBILITY; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FEMALE; INFLAMMATION; LUTEOLIN; MALE; MICE; PARTICLE SIZE; PHOSPHOLIPIDS; PLANT EXTRACTS; RATS, WISTAR; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; WATER;

EID: 84939874220     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12280     Document Type: Article

References (43)

1. Barnes PM, et al. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004; 343: 1-19.
2. Sasidharan S, et al. Isolation and characterization of bioactive compounds from plants' extracts. Afr J Tradit Complement Altern Med 2011; 8: 1-10.
3. Manach C, et al. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005; 81 (Suppl.): 230S-242S.
4. Manach C, et al. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004; 79: 727-747.
5. Teng Z, et al. Intestinal absorption and first-pass metabolism of polyphenol compounds in rat and their transport dynamics in Caco-2 cells. PLoS ONE 2012; 7: 1-9.
6. Singh A, et al. Phytosome: drug delivery system for polyphenolic phytoconstituents. Iran J Pharm Sci 2011; 7: 209-219.
7. Moiteiro C, et al. HPLC quantification of dye flavonoids in Reseda luteola L. from Portugal. J Sep Sci 2008; 31: 3683-3687.
8. Wijayasiriwardena C, et al. Anti-inflammatory activity of Delonix elata (L.) gamble. J Nat Rem 2009; 9: 209-215.
9. Liu R, et al. Luteolin isolated from the medicinal plant Elsholtzia rugulosa (Labiatae) prevents copper-mediated toxicity in β-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells. Molecules 2011; 16: 2084-2096.
10. Farombi EO, Owoeye O,. Antioxidative and chemopreventive properties of Vernonia amygdalina and Garcinia biflavonoid. Int J Environ Res Public Health 2011; 8: 2533-2555.
11. Etherton PMK,. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 2002; 113 ((9) Suppl. 2): 71-88.
12. Teng T, et al. Luteolin induced-growth inhibition and apoptosis of human esophageal squamous carcinoma cell line Eca109 cells in vitro. Asian Pac J Cancer Prev 2012; 13: 5455-5461.
13. Sadik CD, et al. Inhibition of 15-lipoxygenases by flavonoids: structure-activity relations and mode of action. Biochem Pharmacol 2003; 65: 773-781.
14. Moreno DA,. Effects of Arachis hypogaea nutshell extract on lipid metabolic enzymes and obesity parameters. Life Sci 2006; 78: 2797-2803.
15. Wang GG,. Protective effects of luteolin on diabetic nephropathy in STZ-induced diabetic rats. Evid Based Complement Alternat Med 2011; Article ID 323171: 1-7. doi: 10.1155/2011/323171.
16. Park CM, et al. Taraxacum officinale Weber extracts inhibit LPS-induced oxidative stress and nitric oxide production via the NF-κB modulation in RAW 264.7 cells. J Ethnopharmacol 2011; 133: 834-842.
17. Wang X,. Pharmacokinetic interaction between the flavonoid luteolin and γ-hydroxybutyrate in rats: potential involvement of monocarboxylate transporters. AAPS J 2008; 10: 47-55.
18. Chen T,. Absorption and excretion of luteolin and apigenin in rats after oral administration of Chrysanthemum morifolium extract. J Agric Food Chem 2007; 55: 273-277.
19. Rathore P, Swami G,. Planterosomes: a potential phyto-phospholipid carriers for the bioavailability enhancement of herbal extracts. Int J Pharm Sci Res 2012; 3: 737-755.
20. Kidd PM,. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev 2009; 14: 226-246.
21. Kidd P, Head K,. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos). Altern Med Rev 2005; 10: 193-203.
22. Chen ZP, et al. Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats. Fitoterapia 2012; 81: 1045-1052.
23. Tan Q, et al. Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability. AAPS PharmSciTech 2012; 13: 534-547.
24. Shyam KR, et al. Preparation, characterization and antioxidant activities of gallic acid phospholipids complex. Int J Res Pharm Sci 2012; 2: 138-148.
25. Singh D, et al. Emodin-phospholipid complex. J Therm Anal Calorim 2012; 108: 289-298.
26. Goda T, et al. Cell-penetrating macromolecules: direct penetration of amphipathic phospholipid polymers across plasma membrane of living cells. Biomaterials 2010; 31: 2380-2387.
27. FDA-Report. Review of the health aspects of lecithin as a food ingredient. 1977; 751: 78-275.
28. Semalty A,. Supramolecular phospholipids-polyphenolics interactions: the PHYTOSOME strategy to improve the bioavailability of phytochemicals. Fitoterapia 2010; 81: 306-314.
29. Changediya V, et al. Phytosomes: new approach for delivering herbal drug with improved bioavailability. Res J Pharm Biol Chem Sci 2011; 2: 57-68.
30. Kapoor DS, et al. Potential and promises of phospholipid structured novel formulations for hepatoprotection. Int J Drug Dev Res 2012; 4: 51-58.
31. Bhattacharya S.,. Phytosomes: the new technology for enhancement of bioavailability of botanicals and nutraceuticals. Int J Health Res 2009; 2: 225-232.
32. Khan J, et al. Recent advances and future prospects of phyto-phospholipid complexation technique for improving pharmacokinetic profile of plant actives. J Control Release 2013; 168: 50-60.
33. Qin X, et al. Preparation, characterization and in vivo evaluation of bergenin-phospholipid complex. Acta Pharmacol Sin 2012; 31: 127-136.
34. Kim KR, et al. Anti- inflammatory effects of licorice and roasted licorice extracts on TPA-induced acute inflammation and collagen induced arthritis in mice. J Biomed Biotechnol 2010; Article ID 709378: 1-8. doi: 10.1155/2010/709378.
35. Xu Z, et al. Anti-inflammation effects of hydrogen saline in LPS activated macrophages and carrageenan induced paw oedema. J Inflamm 2012; 9: 1-8.
36. Liao CR, et al. Analgesic and anti -inflammatory activities of methanol extract of Ficus pumila L. in mice. Evid Based Complement Alternat Med 2012; Article ID 340141: 1-9. doi: 10.1155/2012/340141.
37. Botsoglou NA, et al. Rapid, sensitive, and specific thiobarbituric method for measuring lipid peroxidation in animal tissue, food, and feed stuff sample. J Agric Food Chem 1994; 42: 1931-1937.
38. Alexander A, et al. Approaches for breaking the barriers of drug permeation through transdermal drug delivery. J Control Release 2012; 164: 26-40.
39. Qiu JF, et al. Preparation and characterization of monomethoxy poly(ethylene glycol)-poly(ε-caprolactone) micelles for the solubilization and in vivo delivery of luteolin. Int J Nanomedicine 2013; 8: 3061-3069.
40. Shaji J, Lal M,. Nanocarriers for targeting in inflammation. Asian J Pharm Clin Res 2013; 6: 3-12.
41. Gupta NK, Dixit VK,. Bioavailability enhancement of curcumin by complexation with phosphatidyl choline. J Pharm Sci 2011; 100: 1987-1995.
42. Calou IB, et al. Topically applied diterpenoids from Egletes viscosa (Asteraceae) attenuate the dermal inflammation in mouse ear induced by Tetradecanoylphorbol 13-acetate- and oxazolone. Biol Pharm Bull 2008; 31: 1511-1516.
43. Igbe I, Inarumen GO,. The effect of leaf aqueous extract of brachystegia eurycoma harms (fabaceae) in acute and chronic inflammatory animal models. British J Pharm Res 2013; 3: 391-400.